|View printer-friendly version|
|November 09, 2003 4:50 p.m.|
|Teva Announces Approval Of Mupirocin Ointment|
Jerusalem, Israel, November 9, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has approved the company's ANDA for Mupirocin Ointment USP, 2%. Shipment of the product will begin immediately.